Synonyms: AMR-101 | icosapent ethyl | icosapentate | Vascepa® | Vazkepa®
icosapent is an approved drug (FDA (2012), EMA (2021))
Compound class:
Synthetic organic
Comment: Icosapent is a synthetic ethyl ester derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is de-esterified during absorption to active EPA that is absorbed in the small intestine.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2012), EMA (2021)) |
IUPAC Name |
ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate |
International Nonproprietary Names | |
INN number | INN |
6328 | icosapent |
Synonyms |
AMR-101 | icosapent ethyl | icosapentate | Vascepa® | Vazkepa® |
Database Links | |
CAS Registry No. | 86227-47-6 |
ChEMBL Ligand | CHEMBL2095209 |
DrugBank Ligand | DB08887 |
DrugCentral Ligand | 1413 |
GtoPdb PubChem SID | 178104013 |
LIPID MAPS | LMFA07010877 |
PubChem CID | 9831415 |
Search Google for chemical match using the InChIKey | SSQPWTVBQMWLSZ-AAQCHOMXSA-N |
Search Google for chemicals with the same backbone | SSQPWTVBQMWLSZ |
Search PubMed clinical trials | icosapent |
Search PubMed titles | icosapent |
Search PubMed titles/abstracts | icosapent |
UniChem Compound Search for chemical match using the InChIKey | SSQPWTVBQMWLSZ-AAQCHOMXSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SSQPWTVBQMWLSZ-AAQCHOMXSA-N |
Wikipedia | Ethyl eicosapentaenoic acid |